Bradley & Co Private Wealth Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11K | Hold |
1,000
| – | – | ﹤0.01% | 172 |
|
|
2025
Q1 | $1.22K | Hold |
1,000
| – | – | ﹤0.01% | 170 |
|
|
2024
Q4 | $1.29K | Buy |
+1,000
| New | +$1.29K | ﹤0.01% | 170 |
|
|
2024
Q2 | $2.26K | Hold |
1,000
| – | – | ﹤0.01% | 156 |
|
|
2024
Q1 | $2.39K | Hold |
1,000
| – | – | ﹤0.01% | 160 |
|
|
2023
Q4 | $1.66K | Hold |
1,000
| – | – | ﹤0.01% | 175 |
|
|
2023
Q3 | $1.92K | Hold |
1,000
| – | – | ﹤0.01% | 157 |
|
|
2023
Q2 | $1.44K | Hold |
1,000
| – | – | ﹤0.01% | 160 |
|
|
2023
Q1 | $2.1K | Hold |
1,000
| – | – | ﹤0.01% | 155 |
|
|
2022
Q4 | $1.13K | Hold |
1,000
| – | – | ﹤0.01% | 162 |
|
|
2022
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 166 |
|
|
2022
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 177 |
|
|
2022
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 143 |
|
|
2021
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 148 |
|
|
2021
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 147 |
|
|
2021
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 152 |
|
|
2021
Q1 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 158 |
|